Below is a featured video from the July 2025 case conference, during which Elizabeth Swisher, MD from the University of Washington discusses Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) following PARP inhibitor therapy.
ICARE Featured Video July 2025
Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Following PARP Inhibitor Therapy
ICARE Featured Video July 2025
Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Following PARP Inhibitor Therapy
Permanent link to this article: https://inheritedcancer.net/video71025/